Preclinical Research with a First-in-Class ALS Therapy Formulation

• Craweled on Oct. 8, 2024, 8:53 p.m.

Preclinical Research with a First-in-Class ALS Therapy Formulation

We are pleased to present our research poster detailing our preclinical study on a first-in-class ALS therapy formulation. This work was showcased at the ALS Drug Development Summit in Boston.

View our research poster below.

• • Canurta